Literature DB >> 20058137

Pulmonary angioplastic procedure for lung cancer surgery.

Motohiro Yamashita1, Eisaku Komori, Shigeki Sawada, Hiroshi Suehisa, Isao Nozaki, Akira Kurita, Shigemitsu Takashima.   

Abstract

PURPOSE: Although bronchoplasty for the treatment of lung cancer is widely accepted as a reliable, safe procedure for the preservation of lung function, there have been only a few reports on pulmonary artery (PA) resection and reconstruction.
METHODS: Retrospectively, we reviewed our medical records of pulmonary angioplastic procedures and assessed the results.
RESULTS: A total of 25 patients (5 women, 20 men) with a mean age of 68 years (range 44-85 years) underwent a pulmonary angioplastic procedure for lung cancer surgery. Altogether, 13 patients had adenocarcinoma, and 11 had squamous cell carcinoma. The cancers were located in the left lung in 15 cases and in the right lung in 10 cases. The PA reconstructions comprised 4 circumferential resections and anastomoses, 18 wedge resections and end-to-end anastomoses, 2 tangential resections with direct suturing, and 1 wide wedge resection and autologous pericardial patch repair. Six patients underwent concomitant bronchoplasty with pulmonary artery reconstruction. Prior to surgical treatment, seven patients had received neoadjuvant therapy. Although early postoperative complications occurred in eight patients (32%), no operative or in-hospital deaths occurred. All the patients in this series were discharged from hospital and went home. The overall 5-year survival rate was 45%, with a mean 27 months of follow-up.
CONCLUSION: Most operative complications after PA reconstruction were controllable despite the high morbidity rate. Pulmonary angioplastic procedures for the surgical treatment of lung cancer are both useful and feasible with good intermediate-term results.

Entities:  

Mesh:

Year:  2010        PMID: 20058137     DOI: 10.1007/s11748-009-0462-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  18 in total

Review 1.  Morbidity and mortality after pneumonectomy.

Authors:  J Klemperer; R J Ginsberg
Journal:  Chest Surg Clin N Am       Date:  1999-08

2.  Lobectomy with tangential pulmonary artery resection without regard to pulmonary function.

Authors:  J B Shrager; E S Lambright; C M McGrath; P M Wahl; M E Deeb; J S Friedberg; L R Kaiser
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

3.  Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.

Authors:  Jean Deslauriers; Jocelyn Grégoire; Louis F Jacques; Michel Piraux; Liu Guojin; Yves Lacasse
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

4.  Sleeve lobectomy versus pneumonectomy: tumor characteristics and comparative analysis of feasibility and results.

Authors:  Patrick Bagan; Pascal Berna; Joao Carlos Das Neves Pereira; Françoise Le Pimpec Barthes; Christophe Foucault; Antoine Dujon; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

5.  Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies.

Authors:  H C Suen; B F Meyers; T Guthrie; M S Pohl; S Sundaresan; C L Roper; J D Cooper; G A Patterson
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

6.  Bronchovascular versus bronchial sleeve resection for central lung tumors.

Authors:  Henning F Lausberg; Thomas P Graeter; Dietmar Tscholl; Olaf Wendler; Hans-Joachim Schäfers
Journal:  Ann Thorac Surg       Date:  2005-04       Impact factor: 4.330

7.  Long-term results of sleeve lobectomy for lung cancer.

Authors:  F Tronc; J Grégoire; J Rouleau; J Deslauriers
Journal:  Eur J Cardiothorac Surg       Date:  2000-05       Impact factor: 4.191

8.  Evaluation of cases with combined bronchoplasty and pulmonary arterioplasty for the treatment of lung cancer.

Authors:  H Wada; K Okubo; T Hirata; S Hitomi
Journal:  Lung Cancer       Date:  1995-10       Impact factor: 5.705

9.  Factors affecting survival after bronchoplasty and broncho-angioplasty for lung cancer: single institutional review of 147 patients.

Authors:  Takeshi Nagayasu; Keitaro Matsumoto; Tsutomu Tagawa; Akihiro Nakamura; Naoya Yamasaki; Atsushi Nanashima
Journal:  Eur J Cardiothorac Surg       Date:  2006-02-13       Impact factor: 4.191

Review 10.  Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis.

Authors:  Zhiyuan Ma; Aiqiang Dong; Junqiang Fan; Haifeng Cheng
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-17       Impact factor: 4.191

View more
  4 in total

1.  Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancer.

Authors:  Cheng-Bo Han; Wei-Li Wang; Leslie Quint; Jian-Xin Xue; Martha Matuszak; Randall Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-28       Impact factor: 7.038

2.  Importance of follow-up inspection after pulmonary angioplastic procedures for lung cancer surgery.

Authors:  Takeshi Nagayasu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-01-09

Review 3.  Lobectomy with angioplasty: which is the best technique for pulmonary artery reconstruction?

Authors:  Jacopo Vannucci; Alberto Matricardi; Rossella Potenza; Mark Ragusa; Francesco Puma; Lucio Cagini
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?

Authors:  Jie-Tao Ma; Li Sun; Xin Sun; Zhi-Cheng Xiong; Yang Liu; Shu-Ling Zhang; Le-Tian Huang; Cheng-Bo Han
Journal:  Radiat Oncol       Date:  2017-02-01       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.